Perrigo Co (BSP:P1RG34) Short-Term Debt : R$2,194 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Perrigo Co Short-Term Debt?

Perrigo Co's Short-Term Debt for the quarter that ended in Mar. 2024 was R$2,194 Mil.

Perrigo Co's quarterly Short-Term Debt increased from Sep. 2023 (R$188 Mil) to Dec. 2023 (R$2,159 Mil) and increased from Dec. 2023 (R$2,159 Mil) to Mar. 2024 (R$2,194 Mil).

Perrigo Co's annual Short-Term Debt declined from Dec. 2021 (R$3,414 Mil) to Dec. 2022 (R$190 Mil) but then increased from Dec. 2022 (R$190 Mil) to Dec. 2023 (R$2,159 Mil).

Perrigo Co Short-Term Debt Historical Data

The historical data trend for Perrigo Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Short-Term Debt Chart

Perrigo Co Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

13.96

191.90

3,414.43

189.88

2,158.85

Perrigo Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															202.09	186.38	188.16	2,158.85	2,194.10

Perrigo Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Perrigo Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Perrigo Co (BSP:P1RG34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (BSP:P1RG34) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

PRGO:USA PIG:Germany

Address

The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74

Website

https://www.perrigo.com

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co (BSP:P1RG34) Headlines

No Headlines